J&J may have to compensate for faulty hip implants

img{border:0;clear:both;display:block;float:none;height:auto !important;margin: 3px 10px 3px 0;max-width:100% !important}
object, embed{border:0;clear:both;display:block;float:none}
a img{text-decoration:none}
.content * {font-family:’AvenirNext-Regular’, Avenir, ‘Helvetica Neue’, Arial, Helvetica, sans-serif;font-size:18px;line-height:1.4;color:#333 !important;}
font {line-height: inherit !important; font-size: inherit !important}
a, a:visited, .content a {color:#09f !important;text-decoration:none !important}
h1 a {color: white !important}

h1 {font-size:36px !important}
h2 {font-size:27px !important}
h3 {font-size:21px !important}
h4 {font-size:18px !important}
h5 {font-size:18px !important}
h6 {font-size:18px !important}
h1, h2, h3 { line-height: 1.125 !important }
h4, h5, h6 { line-height: 1.25 !important }

@media screen and (max-width:700px) {
.content {
width: 100%!important;

The reason it has taken so long to arrive at this decision is because there is currently no provision to compensate patients for drugs and devices that are already approved in the market, said officials.

via Industry-The Economic Times https://ift.tt/2BRzYLo

RSS Feed

RSS feed to email